title: Hemoperitoneum in a continuous ambulatory peritoneal dialysis patient caused by a hepatocarcinoma treated with percutaneous embolization.
abstract: Hemoperitoneum is an infrequent but normally benign complication in continuous ambulatory peritoneal dialysis (CAPD) patients. It can occur at any time during peritoneal dialytic treatment. Hemoperitoneum is not associated with a specific disease and usually disappears spontaneously. In 20% of cases, however, hemoperitoneum is severe and requires specific investigation and emergency therapy. We report a case of hemoperitoneum in a 70-year-old, anti-hepatitic C virus-positive woman. After 48 months of CAPD treatment, a bloody peritoneal effluent developed, with severe anemia (hematocrit decreased from 30% to 20%). An abdominal computed tomography scan showed three hepatic lesions with signs of hepatic neoplasms; selective hepatic arteriography confirmed the diagnosis. Chemoembolization of the three lesions was performed, and hemoperitoneum disappeared within a few hours.
authors.affiliation: Renal Unit and Radiology Unit, Desio Hospital, Milan, Italy. mariabeatrice.dozio@tin.it
authors.forename: B
authors.initials: B
authors.lastname: Dozio
authors.forename: R
authors.initials: R
authors.lastname: Scanziani
authors.forename: G
authors.initials: G
authors.lastname: Rovere
authors.forename: L
authors.initials: L
authors.lastname: Sangalli
authors.forename: S
authors.initials: S
authors.lastname: Sacerdoti
authors.forename: M
authors.initials: M
authors.lastname: Surian
mesh_terms: D000368:Aged; D000740:Anemia / Q000209:etiology / Q000628:therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000628:therapy; D003287:Contrast Media / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004621:Embolization, Therapeutic / Q000379:methods*; D017809:Fatal Outcome; D005260:Female; D005781:Gelatin Sponge, Absorbable / Q000627:therapeutic use; D006465:Hemoperitoneum / Q000209:etiology* / Q000628:therapy; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D007459:Iodized Oil / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000150:complications* / Q000628:therapy; D010531:Peritoneal Dialysis, Continuous Ambulatory
chemical_list: D000970:Antineoplastic Agents; D003287:Contrast Media; D006490:Hemostatics; D007459:Iodized Oil; D004317:Doxorubicin